COFOE Medical Reports Half-Year Results with Net Profit Attributable to Shareholders Reaching RMB 202 Million, Up 20.84% Year-on-Year
Stock News
Aug 28
COFOE MEDICAL (01187) has unveiled its performance figures for the six months ended June 30, 2026, showcasing robust growth in its core financial metrics.
During the reporting period, the group achieved revenue of RMB 2.072 billion, representing a substantial year-on-year increase of 38.51%. Meanwhile, profit attributable to shareholders of the parent company reached RMB 202 million, up 20.84% compared to the same period last year.
The company also reported basic earnings per share of RMB 0.95 for the interim period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.